GC Biopharma, a leading global pharmaceutical company based in South Korea, announced today that the Phase 2 clinical trial ...
Dear Savvy Senior, With a longtime vaccine critic leading the nation’s health departments, can you give me updated ...
HealthDay on MSN
Two-Dose Recombinant Zoster Vaccine Effective in Older Adults, Regardless of Prior Vaccination
Two doses of the recombinant zoster vaccine are effective in older adults, including immunocompromised adults.
Immunologist Zachary Rubin explains how the World Health Organization decides which strains of influenza end up in annual flu ...
CSL ( ASX: CSL) cut its fiscal 2026 guidance for revenue and net profit after tax before amortization growth to 3% and 6% at ...
Ted Jin, founder and CEO of AuX Labs, is leading a charge in the food technology space with a mission driven by global impact ...
TipRanks on MSN
Protalix Seeks EMA Re-examination for Elfabrio Dosing
Protalix ( ($PLX) ) has issued an update. On November 3, 2025, Protalix BioTherapeutics and Chiesi Global Rare Diseases announced their request ...
Savara Inc. (NASDAQ:SVRA) is one of the best stocks under $5 with highest upside potential. On October 23, Citizens JMP ...
Flanders Institute for Biotechnology (VIB), biologist Jessie Vandierendonck has been investigating new, alternative ...
A case of membranoproliferative glomerulonephritis with immune depositions in the kidney was reported during clinical trials. Monitor serum creatinine and urinary protein-to-creatinine ratio. If ...
A case of membranoproliferative glomerulonephritis with immune depositions in the kidney was reported during clinical trials. Monitor serum creatinine and urinary protein-to-creatinine ratio. If ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback